Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Nasdaq: AGIO
    
Event Details

Q4 2016 Agios Pharmaceuticals Inc Earnings Conference Call

Thursday, February 16, 2017 8:00 a.m. ET  
Title
Q4 2016 Agios Pharmaceuticals Inc Earnings Conference Call
Date / Time
02/16/17 8:00 a.m. ET